logo

Alzheimer's Drugs In Late Stage Pipeline

No New Alzheimers drug has been approved since 2003
No New Alzheimers drug has been approved since 2003

Alzheimer's is the 6th leading cause of death in the U.S., and there is no cure yet for this neurodegenerative disease. The available medications for Alzheimer's can only alleviate symptoms temporarily, and they don't work for everyone.

The FDA-approved medications to treat the symptoms of Alzheimer's disease include:

-- Donepezil, marketed under the brand name Aricept, to treat all stages of the disease
-- Galantamine, marketed under the brand name Razadyne, for mild-to-moderate stages
-- Memantine, marketed under the brand name Namenda, and Memantine/Donepezil combo drug, marketed under the brand name Namzaric, to treat moderate to severe stages
-- Rivastigmine, marketed under the brand name Exelon, for all stages of Alzheimer's.

No new Alzheimer's drug has been approved since 2003 - the year, in which Forest Labs' Namenda was approved in the U.S.

Let’s take a look at companies whose Alzheimer's drugs are in phase III development.

Share